Earth Life Sciences Inc.
CLTS · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $0 | $0 |
| Sales & Mktg Exp. | $2 | $2 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$1 |
| Operating Expenses | $2 | $2 | $0 | $0 |
| Operating Income | -$2 | -$2 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$2 | -$2 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS | -0.003 | -0.004 | -0 | -0.001 |
| % Growth | 23.8% | -2,000% | 84.6% | – |
| EPS Diluted | -0.003 | -0.004 | -0 | -0.001 |
| Weighted Avg Shares Out | 495 | 438 | 333 | 333 |
| Weighted Avg Shares Out Dil | 495 | 438 | 333 | 333 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $0 | $0 | $0 |
| EBITDA | $0 | -$2 | -$0 | -$0 |
| % Margin | – | – | – | – |